WallStreetZenWallStreetZen

NASDAQ: PRLD
Prelude Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PRLD

Based on 3 analysts offering 12 month price targets for Prelude Therapeutics Inc.
Min Forecast
$4.00-4.31%
Avg Forecast
$5.33+27.58%
Max Forecast
$7.00+67.46%

Should I buy or sell PRLD stock?

Based on 3 analysts offering ratings for Prelude Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their PRLD stock forecasts and price targets.

PRLD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2023-12-19

1 of 1

Forecast return on equity

Is PRLD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is PRLD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PRLD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRLD$4.18$5.33+27.58%Hold
ALDX$3.97$10.00+151.89%Buy
ACRV$10.34$16.50+59.57%Strong Buy
ADVM$11.35$33.33+193.68%Strong Buy
GTHX$4.28$8.00+86.92%Buy
View Top Biotech Stocks

Prelude Therapeutics Stock Forecast FAQ

Is Prelude Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PRLD) stock is to Hold PRLD stock.

Out of 3 analysts, 0 (0%) are recommending PRLD as a Strong Buy, 1 (33.33%) are recommending PRLD as a Buy, 1 (33.33%) are recommending PRLD as a Hold, 0 (0%) are recommending PRLD as a Sell, and 1 (33.33%) are recommending PRLD as a Strong Sell.

If you're new to stock investing, here's how to buy Prelude Therapeutics stock.

What is PRLD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PRLD) forecast ROE is N/A, which is considered weak.

What is PRLD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PRLD price target, the average PRLD price target is $5.33, with the highest PRLD stock price forecast at $7.00 and the lowest PRLD stock price forecast at $4.00.

On average, Wall Street analysts predict that Prelude Therapeutics's share price could reach $5.33 by Mar 13, 2025. The average Prelude Therapeutics stock price prediction forecasts a potential upside of 27.58% from the current PRLD share price of $4.18.

What is PRLD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PRLD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.